Quanyuan Pharmaceuticals (300254.SZ) plans to launch a restricted stock incentive plan for up to 9.15 million shares.

Wisdom Finance APP News, Qianyuan Medicine (300254.SZ) disclosed the 2025 restricted stock incentive plan (draft), planning to grant a total of no more than 9.15 million restricted stocks to incentive recipients, accounting for 3.68% of the total share capital of the company at the time of the announcement of this draft incentive plan. Among them, 7.95 million stocks will be granted for the first time, with a total of 171 incentive recipients, and the grant price (including reservation) is 5.60 yuan per share.